Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-10

Clinical Trial Update: Cyclic Versus Daily Teriparatide on Bone Mass [Phase 2]

View source ↗

Summary

Phase 2 trial comparing cyclic versus daily teriparatide for bone mass in osteoporosis; the update does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)

Snippet

Sponsor: Helen Hayes Hospital | Conditions: Osteoporosis | Phase 2 | Status: UNKNOWN